Where Women's Health Gets Funded

The investors are already paying attention. The only question is whether you're in the room. Two days, 700+ investors, corporates and founders, one stage in London.

Meet Investors From Pre-Seed to Series A

The investors in the room range from specialist femtech funds to generalist VCs finally paying attention, plus the corporate venture arms with actual checks to write. None of them are on a panel three floors away — they're in the room, in your meetings, at the bar after.

You'll be sharing a room with investors and corporates including

Investors & Funds
3 Futures Fund, Aegis Ventures, Amboy Street Ventures, American Heart Association (Go Red for Women Venture Fund), Angelini Ventures, Antler, Astia, Astorg, BBG Ventures, Big Issue Invest, Black Opal Ventures, Blackstone, Borski Fund, Calm/Storm Ventures, Catalytic Impact Foundation, CofoundHer Capital, Cross Border Impact Ventures, Dalloway Partners, Eka Ventures, Fabric VC, Feast Ventures, FemHealth Ventures, Fern Capital Group, Flare Capital, FORCE Family Office, Foreground Capital, Frazier Partners, FSV, Future Heights Ventures, G9 Ventures, General Atlantic, GG Ventures, GHO Capital, Gresham House, Hysteria Ventures, Impact Invest, Impact Invest Scandinavia, Impulse Impact, Inflect Capital, Juno Fund, Kerna Ventures, Kidron Capital, Lauxera Capital Partners, Lavender Ventures, Mariour Capital, Meridian Street Capital, Monarch Collective, Muse Capital, MVM, NGBio, Novo Holdings, Octopus Ventures, Panakes SGR, Patient Partner Capital, Planet First Partners, Portfolia, Rhia Ventures, Rogue Women's Fund, Samsung Next, Sie Ventures, Araya Ventures, Springboard Enterprises, Stagshorn Ventures, Supernode Global, TELUS Global Ventures, THENA Capital, Verdane
Corporates, Pharma & Retail
Amazon, Amazon One Medical, Amazon Pharmacy, Bayer, Boots UK, Bupa, BVD Healthcare, Carrot, CVS Health, Dexcom, Ferring, Function Health, Garmin Health (Garmin), Google, Fitbit, Google Deepmind, Haleon, Healogix, Holland and Barrett, Hologic, Initiator Pharma, Johnson & Johnson, Kaiser Permanente, Labcorp, Lloyds / Pharmacy2U, Merck, Nestlé, Novo Nordisk, Oak Street Health, Organon, Otsuka Precision Health, Oura, Pfizer, Philips, Publicis Health, Reckitt, Roche, Sanofi, Sebela Women's Health Inc, Theramex, Uber Health
Banks, Advisors & Institutions
&Robin, Baker Tilly, Barclays Business Banking, British Business Bank, Citi, Deloitte, EY Parthenon, GlobalData, Goldman Sachs, HSBC Innovation Banking, J.P. Morgan, NYSE, PwC, Scottish National Investment Bank

Plus: GCWC, WHAM, Manchester City Women
Pitch in front of the Entire Women’s Health Ecosystem

16 disruptive innovators will be given the chance to pitch on the mainstage at WHW Europe in front of a curated audience of innovators, investors, corporates, and partners actively seeking solutions that can scale.

Women’s Health Week Europe brings together the leaders shaping the future of women’s health all across the European region.Any company treating a condition that affects women exclusively, differently, or disproportionately can apply, this is your chance to showcase your company as the next big thing in women’s health.

Applications close 28 August

Medical Devices & Therapeutics

Companies building regulated, clinical, or science-led solutions that diagnose, treat, or prevent.

  • Medical Devices

  • Therapeutics & pharma innovation

  • Regulated Digital Health

  • Deep-Tech or Science-Led Platforms

Consumer & Tech

Companies improving women’s health through consumer products, digital tools, or services

  • Consumer Health & Wellness Brands

  • Digital Health Platforms

  • Wearables, Data & Connected Text

  • Employer, Payor or Benefit-Led Solutions

  • Commerce, Marketplace, and Services

Testimonials

The most commercially concentrated room in women's health, full stop. In two days I reached strategic investors, OEM partners, payors and clinical KOLs that would take 6+ months of cold outreach. Highest-ROI conference of my year.

Robert Bunn
Founder & President, ultrasound.ai

Women’s Health Week - where women's health stops being overlooked and starts becoming an opportunity

Alia Kozlova
CEO, Innovene Therapeutics

WHW 2026 had all the right people in the room. Women's health has advanced from being a hope & a dream, to being real regulations, real companies, and real investment. WHW 2026 will accelerate this even further.

Elise King
Managing Director, AHA Ventures